Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Polymeric Nanoparticles for Dna Vaccine-Based Cancer Immunotherapy: A Review Publisher Pubmed



Danaeifar M1 ; Negahdari B1 ; Eslam HM2 ; Zare H3 ; Ghanaat M4 ; Koushali SS3 ; Malekshahi ZV1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran
  4. 4. Department of Microbiology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran

Source: Biotechnology Letters Published:2023


Abstract

Cancer is one of the leading causes of death and mortality in the world. There is an essential need to develop new drugs or therapeutic approaches to manage treatment-resistant cancers. Cancer immunotherapy is a type of cancer treatment that uses the power of the body’s immune system to prevent, control, and eliminate cancer. One of the materials used as a vaccine in immunotherapy is DNA. The application of polymeric nanoparticles as carriers for DNA vaccines could be an effective therapeutic approach to activate immune responses and increase antigen presentation efficiency. Various materials have been used as polymeric nanoparticles, including: chitosan, poly (lactic-co-glycolic acid), Polyethylenimine, dendrimers, polypeptides, and polyesters. Application of these polymer nanoparticles has several advantages, including increased vaccine delivery, enhanced antigen presentation, adjuvant effects, and more sustainable induction of the immune system. Besides many clinical trials and commercial products that were developed based on polymer nanoparticles, there is still a need for more comprehensive studies to increase the DNA vaccine efficiency in cancer immunotherapy using this type of carrier. © 2023, The Author(s), under exclusive licence to Springer Nature B.V.
Related Docs
View other Related Docs
1. Dna Vaccines As Promising Immuno-Therapeutics Against Cancer: A New Insight, Frontiers in Immunology (2024)
2. Nanoparticles in Cancer Immunotherapies: An Innovative Strategy, Biotechnology Progress (2021)
3. Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy, International Immunopharmacology (2020)
4. Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy, Clinical and Translational Oncology (2023)
5. In-Vitro Tumor Microenvironment Models Containing Physical and Biological Barriers for Modelling Multidrug Resistance Mechanisms and Multidrug Delivery Strategies, Journal of Controlled Release (2021)
6. Delivery Systems for Leishmania Vaccine Development, Expert Review of Vaccines (2016)
7. Nanovehicles for Co-Delivery of Anticancer Agents, Drug Discovery Today (2020)
8. Antitumor Effects of Hpv Dna Vaccine Adjuvanted With Beclin-1 As an Autophagy Inducer in a Mice Model, Iranian Biomedical Journal (2019)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Mahdi Adabi (3)
Other Related Docs
9. Nanovehicle-Based Small Interfering Rna (Sirna) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics, Current Clinical Pharmacology (2018)
10. Delving Into Revolutionary Sars-Cov-2 Vaccine Approaches: Molecular and Virological Examinations; Principles of Sars-Cov-2 Vaccine Platform; [Adentrandose En Enfoques Revolucionarios De Vacunas Sars-Cov-2: Examenes Moleculares Y Virologicos; Principios De La Plataforma De Vacunas Sars-Cov-2], Vacunas (2024)
11. Emerging Innovations in Vincristine-Encapsulated Nanoparticles: Pioneering a New Era in Oncological Therapeutics, Journal of Drug Delivery Science and Technology (2024)
12. Revisiting Structure-Property Relationship of Ph-Responsive Polymers for Drug Delivery Applications, Journal of Controlled Release (2017)
13. In-Vitro and In-Vivo Comparison of Rsag1-Loaded Plga Prepared by Encapsulation and Adsorption Methods As an Efficient Vaccine Against Toxoplasma Gondii”, Journal of Drug Delivery Science and Technology (2020)
14. Combining Anti-Checkpoint Immunotherapies and Cancer Vaccines As a Novel Strategy in Oncological Therapy: A Review, Human Immunology (2025)
15. Synergistic Effect of Rsag1 and Rgra2 Antigens Formulated in Plga Microspheres in Eliciting Immune Protection Against Toxoplasama Gondii, Experimental Parasitology (2016)
16. Novel Approach to Improve Vaccine Immunogenicity: Mannosylated Chitosan Nanoparticles Loaded With Recombinant Hepatitis B Antigen As a Targeted Vaccine Delivery System, Journal of Drug Delivery Science and Technology (2018)
17. Nanovaccines for Cancer Immunotherapy: Focusing on Complex Formation Between Adjuvant and Antigen, International Immunopharmacology (2023)
18. Biomedical Applications of Intelligent Nanomaterials, Intelligent Nanomaterials: Second Edition (2016)
19. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
20. Intravenous Injection of Myelin Oligodendrocyte Glycoprotein-Coated Plga Microparticles Have Tolerogenic Effects in Experimental Autoimmune Encephalomyelitis, Iranian Journal of Allergy# Asthma and Immunology (2017)
21. Inhibition of Octreotide Acylation Inside Plga Microspheres by Derivatization of the Amines of the Peptide With a Self-Immolative Protecting Group, Bioconjugate Chemistry (2016)
22. Nano-Scale Delivery Systems for Sirna Delivery in Cancer Therapy: New Era of Gene Therapy Empowered by Nanotechnology, Environmental Research (2023)
23. In Vitro Elimination of El4 Cancer Cells From Spermatogonia Stem Cells by Mirna-143- a Nd 206-Loaded Folic Acid-Conjugated Plga Nanoparticles, Nanomedicine (2022)
24. Polyphenol Nanoformulations for Cancer Therapy: Experimental Evidence and Clinical Perspective, International Journal of Nanomedicine (2017)
25. Influenza Vaccine: Where Are We and Where Do We Go?, Reviews in Medical Virology (2019)
26. Encapsulation: Controlled Drug Delivery, Principles of Biomaterials Encapsulation: Volume 2 (2023)
27. Recent Advances on Biocompatible and Biodegradable Nanoparticles As Gene Carriers, Expert Opinion on Biological Therapy (2016)
28. Genetic Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
29. Preparation of Curcumin-Loaded Plga Nanoparticles and Investigation of Its Cytotoxicity Effects on Human Glioblastoma U87mg Cells, Biointerface Research in Applied Chemistry (2019)
30. Methylated 4-N,N Dimethyl Aminobenzyl N,O Carboxymethyl Chitosan As a New Chitosan Derivative: Synthesis, Characterization, Cytotoxicity and Antibacterial Activity, Carbohydrate Polymers (2016)
31. Effect of Paclitaxel/Etoposide Co-Loaded Polymeric Nanoparticles on Tumor Size and Survival Rate in a Rat Model of Glioblastoma, International Journal of Pharmaceutics (2021)
32. Hbs Antigen and Mannose Loading on the Surface of Iron Oxide Nanoparticles in Order to Immuno-Targeting: Fabrication, Characterization, Cellular and Humoral Immunoassay, Artificial Cells# Nanomedicine and Biotechnology (2019)
33. Suppression of Chronic Inflammation With Engineered Nanomaterials Delivering Nuclear Factor Jb Transcription Factor Decoy Oligodeoxynucleotides, Drug Delivery (2017)
34. Glyco-Nanoparticles: New Drug Delivery Systems in Cancer Therapy, Seminars in Cancer Biology (2021)
35. Recent Progress in Cancer Immunotherapy: Overview of Current Status and Challenges, Pathology Research and Practice (2023)
36. Exploitation of Renewable Energy Sources for Water Desalination Using Biological Tools, Environmental Science and Pollution Research (2023)
37. Could Artificial Intelligence Revolutionize the Development of Nanovectors for Gene Therapy and Mrna Vaccines?, Nano Today (2022)
38. Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects, Biomedicine and Pharmacotherapy (2022)
39. Downregulation of Cd73 in 4T1 Breast Cancer Cells Through Sirna-Loaded Chitosan-Lactate Nanoparticles, Tumor Biology (2016)
40. Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021), Current Pharmaceutical Biotechnology (2023)
41. Mrna Cancer Vaccines From Bench to Bedside: A New Era in Cancer Immunotherapy, Biomarker Research (2024)
42. Advances in Cancer Nanovaccines: A Focus on Colorectal Cancer, Nanomedicine (2025)
43. Future Perspective on the Smart Delivery of Biomolecules, Drug Delivery Systems (2017)
44. Challenges in the Delivery of Polyphenols to Cancer Cells, Mitochondrial Dysfunction and Nanotherapeutics: Aging# Diseases# and Nanotechnology-Related Strategies in Mitochondrial Medicine (2021)
45. Nanoparticles: Novel Vehicles in Treatment of Glioblastoma, Biomedicine and Pharmacotherapy (2016)
46. Co-Utilization of a Tlr5 Agonist and Nano-Formulation of Hiv-1 Vaccine Candidate Leads to Increased Vaccine Immunogenicity and Decreased Immunogenic Dose: A Preliminary Study, Immunology Letters (2017)
47. Self-Assembling Peptide Epitopes As Novel Platform for Anticancer Vaccination, Molecular Pharmaceutics (2017)
48. Controlled Anti-Cancer Drug Release Through Advanced Nano-Drug Delivery Systems: Static and Dynamic Targeting Strategies, Journal of Controlled Release (2020)
49. The Potential Use of Therapeutics and Prophylactic Mrna Vaccines in Human Papillomavirus (Hpv), Virology Journal (2024)
50. Vaccines, Adjuvants, and Delivery Systems, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)